Webinar: 2020 pan-Canadian Oncology Drug Review (pCODR) Updates

By Innomar Strategies |

Ferg Mills, Director of Strategic Consulting, and George Wyatt, Executive Senior Consultant at InnomarConsulting, dig into the pan-Canadian Oncology Drug Review (pCODR) initiatives introduced in the first half of 2020.

You will gain valuable insights on:
  • Provide an update on activity in oncology HTA
  • Highlight trends and patterns, and explore some informative case studies that may provide insights for submitters
  • Review recent and anticipated process changes
  • Audience questions

The goal of this webinar is to provide some strategic guidance to submitters regarding best practices, product positioning and submission timing.


Learn more

Connect With an Expert

Find out how Innomar Strategies can help you prepare for commercialization success in the Canadian market. 

Contact us

Topics:
Market Access